HPLC-MS determination of pharmacokinetic of ondansetron in human plasma and its bioequivalence
Luo Yi
Abstract
Luo Yi
Abstract
Objectives:To establish an HPLC-MS method for determination of pharmacokinetic of ondansetron in human plasma,and to study the bioequivalence of ondansetron hydrochloride oral solution.Methods:Twenty healthy male volunteers were orally administered with a randomized and single crossover dose of ondansetron hydrochloride oral solution(test sample) and ondansetron hydrochloride tablets(reference sample)8 mg.The plasma ondansetron were quantified by HPLC-MS(SIM+).The pharmacokinetics parameters and relative bioavailability were calculated using DAS 2.0.Results:The main pharmacokinetic parameters of test and reference preparation were as followed: tmax were(1.65±0.46)h and(1.60±0.62) h,Cmax were(57.58±14.11)ng·mL-1 and(53.01±16.24)ng·mL-1,t1/2 were(3.50±0.80)h and(4.13±1.25)h,AUC(0→24)were(353.63±75.84)ng·h·mL-1 and(326.02±104.49)ng·h·mL-1.Conclusion:The results show that the two formulations are bioequivalent.The relative bioavailability of ondansetron hydrochloride oral solution is 110.9%.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objectives:To establish an HPLC-MS method for determination of pharmacokinetic of ondansetron in human plasma,and to study the bioequivalence of ondansetron hydrochloride oral solution.Methods:Twenty healthy male volunteers were orally administered with a randomized and single crossover dose of ondansetron hydrochloride oral solution(test sample) and ondansetron hydrochloride tablets(reference sample)8 mg.The plasma ondansetron were quantified by HPLC-MS(SIM+).The pharmacokinetics parameters and relative bioavailability were calculated using DAS 2.0.Results:The main pharmacokinetic parameters of test and reference preparation were as followed: tmax were(1.65±0.46)h and(1.60±0.62) h,Cmax were(57.58±14.11)ng·mL-1 and(53.01±16.24)ng·mL-1,t1/2 were(3.50±0.80)h and(4.13±1.25)h,AUC(0→24)were(353.63±75.84)ng·h·mL-1 and(326.02±104.49)ng·h·mL-1.Conclusion:The results show that the two formulations are bioequivalent.The relative bioavailability of ondansetron hydrochloride oral solution is 110.9%.
Key concepts: Bioequivalence, Ondansetron, Chemistry, Bioavailability, Pharmacokinetics, Cmax, Chromatography, High-performance liquid chromatography